BRAF and small cell lung carcinoma: In a study including 59 patients with SCLC and 1 with combined SCLC histology (not otherwise specified), both in extensive- (n = 27) or limited-stage (n = 33), the assessment of molecular aberration revealed the presence of 1 BRAF V600E mutation in 1 patient, out of 46 samples analyzed for BRAF alterations.